KCNA3 and hematopoietic and lymphoid cell neoplasm: In support of this, Kv1.3 blockade inhibits activation-induced proliferation of malignant T cells (as shown in Figures 2–4), and inhibits cell proliferation in hematological cancers of B cell origin, as shown by others [62, 63].